Molecular Partners
Patrick Amstutz, Ph.D., has been CEO of Molecular Partners since November 2016. He co-founded Molecular Partners and has been a member of the company’s management team since its inception in 2004, also holding the positions of CBO and COO. In those roles, Patrick was responsible for business development, alliance management and research and development operations. He has established a wide range of commercial collaborations and licensed several key technologies. Since 2017, Patrick has been vice president of the board of the Swiss Biotech Association. Patrick holds a Master of Science from the ETH Zurich and a Ph.D. in molecular biology from the University of Zurich. As CEO, Patrick is not a member of any committees of the board of directors of the company.
This person is not in any offices
Molecular Partners
3 followers
About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.